Stosiek U
Geburtshilfe Frauenheilkd. 1975 Jun;35(6):483-8.
This is a study about changes in blood clotting and thrombocyteaggregation in 55 patients with gynecological carcinomas undergoing radiotherapy. The usual thromboembolism prophylaxis were supplemented by 10000 USP-U Heparine administered subcutaneously in 12-hour-intervals. After radiotherapy there was no change in blood clotting values, gross-thrombocyte count or in percentage of thrombocytes involved in aggregation. Aggregation velocity was significantly higher directly after radiotherapy compared to before, it reached normal values after 4 days. The increase was virtually independent of age, body weight or radio therapy dosage. The strangest increase with doubling of normal aggregation speed was found in primary insertions. Second- and third-time insertion showed only smaller increases. Subcutaneous application of Calciparin was simple and painless, in one case the medication had to be discontinued because of a bleeding in the pectoralis area. An increased bleeding tendency was not observed. Thromboembolic complications did not occur.
这是一项关于55例接受放疗的妇科癌症患者血液凝固和血小板聚集变化的研究。常规的血栓栓塞预防措施辅以每12小时皮下注射10000 USP-U肝素。放疗后,血液凝固值、血小板总数或参与聚集的血小板百分比均无变化。与放疗前相比,放疗后聚集速度明显更高,4天后达到正常值。这种增加几乎与年龄、体重或放疗剂量无关。在初次植入时发现聚集速度增加最为显著,正常聚集速度翻倍。第二次和第三次植入时增加幅度较小。皮下注射凯时简单且无痛,有1例因胸肌区域出血而不得不停药。未观察到出血倾向增加。未发生血栓栓塞并发症。